BioCaptiva Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BioCaptiva Ltd. - overview
Established
2018
Location
-, SCT, UK
Primary Industry
Biotechnology
About
Based in St. Andrews, UK, and founded in 2018, BioCaptiva Limited operates as a developer of liquid biopsy technology devices designed to diagnose, monitor, and detect cancers. In March 2026, BioCaptiva Limited raised GBP 1. 58 million in venture funding led by Archangels Investors Limited, with participation from Old College Capital, BBI Capital, Scottish Enterprise, and EverQuest Capital Partners.
BioCaptiva's BioCollector device captures cfDNA (circulating free DNA) from the blood of patients in much greater quantities than the standard of a single blood draw, overcoming a significant current limitation of cancer liquid biopsy testing, which leads to detecting cancer at the early stage. The company plans to use the March 2026 funding to develop its blood sample preparation technology and expand its liquid biopsy product range following the launch of its first research kits in the U. S.
Current Investors
Archangels Investors Limited, Scottish Enterprise, Old College Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Healthcare IT, Medical Devices & Equipment
Website
www.biocaptiva.com
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.